Federal regulators plan to authorize an additional dose for seniors and immunocompromised people in the coming weeks, ahead of the introduction of a newly formulated booster later in the year.
Previous Story
Behind Trump Indictment, the Right Wing Finds a Familiar Villain in Soros
Next Story
Wisconsin’s High-Stakes Supreme Court Race: What to Watch